Home >
Medicine Info >
Envas 1.25 MG Injection
Loading interface...

Envas 1.25 MG Injection

Manufactured byCadila Pharmaceuticals Ltd.
ContainsEnalapril
Description
Envas 1.25 MG Injection is used in the treatment of high blood pressure. It may also be used in the treatment of congestive heart failure which is a type of heart disease, characterized by thickening of the walls of the left ventricle.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Side effects

Major & minor side effects for Envas 1.25 MG Injection

  • Blurred vision
  • Confusion
  • Dizziness when getting up suddenly from a sitting position
  • Cough
  • Chest pain
  • Fever or chills
  • Pain at the injection site
  • Skin rash
  • Lack of strength
  • Increase in the potassium levels

Uses of Envas 1.25 MG Injection

What is it prescribed for?

  • Hypertension
  • Congestive Heart Failure
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 1-2 hours of administration of the dose.
  • How long do the effects of this medicine last?
    The effect of this medicine lasts for an average duration of 6 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as dizziness, lightheadedness, and fainting. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to Enalapril, other ACE inhibitors, or any other inactive ingredients present along with the formulation.

Aliskiren

Coadministration of aliskiren and this medicine is not recommended due to the increased risk of serious adverse effects. This risk is especially higher in the elderly population and in patients with diabetes and kidney diseases.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
General warnings

Hypotension

Symptomatic hypotension may occur in patients with volume depletion or patients who are treated with high-dose diuretics. It is advised to correct this condition before initiating treatment with this medicine. Regular monitoring of blood pressure is recommended during treatment with this medicine. Appropriate dose adjustments should be done based on the clinical condition.

Hyperkalemia

This medicine may increase potassium levels in the blood (hyperkalemia). This may cause serious side effects such as fatal cardiac rhythm irregularities. It is advised to avoid potassium-rich foods (potatoes, bananas) and other medicines that may increase potassium levels (ACE inhibitors, potassium-sparing diuretics, and potassium supplements) during treatment with this medicine.

Cough

This medicine may cause a persistent nonproductive cough in some patients. It is resolved when the medicine is discontinued.

Impaired liver function

This medicine should be used with caution in patients with liver diseases due to the increased risk of worsening of the patient's condition. Close monitoring of liver function is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Missed Dose

Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of a missed dose is very low.

Overdose

Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as dizziness, lightheadedness, and fainting. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
Interaction with Medicine

Losartan

Corticosteroids

Aliskiren

Insulin

Nonsteroidal anti-inflammatory medicines

Disease interactions

Angioedema

This medicine is not recommended for use in patients with a history of angioedema or a family history of angioedema due to the increased risk of recurrent symptoms. Report any incidence of swelling of the face, lips, and eyes to the doctor on priority. Replacement with a suitable alternative may be required based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine relaxes the blood vessels and promotes a smooth flow of the blood.
Legal Status

Approved

Approved

Unknown

Unknown

Classification

Category

Angiotensin converting enzyme inhibitors

Schedule

Schedule H

Enalapril - DrugBank [Internet]. Drugbank.ca. 2020 [cited 9 March 2020]. Available from:

https://www.drugbank.ca/drugs/DB00584

[Internet]. Accessdata.fda.gov. 2020 [cited 9 March 2020]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/075458s007lbl.pdf

Enalapril: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2020 [cited 9 March 2020]. Available from:

https://medlineplus.gov/druginfo/meds/a686022.html
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 13 Mar 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.